Luofang Biotechnology
Latest round
- Seed
Last raised
- Apr 2026
Total raised
- Undisclosed
Investors
- 1
About Luofang Biotechnology
Luofang Biotechnology, founded in 2025 and headquartered in Shenzhen, China, focuses on developing high molecular therapies for chronic health conditions.Polyncure specializes in innovative high molecular therapies aimed at transforming the future of chronic disease management. The company focuses on developing advanced therapeutic solutions that leverage high molecular compounds to address various chronic health conditions. By employing cutting-edge technologies, Polyncure's products are designed to enhance the efficacy and delivery of treatments to patients, ultimately improving health outcomes. The company primarily targets healthcare providers, research institutions, and pharmaceutical partners as its client base, facilitating access to its novel therapies.Polyncure generates revenue through a structured transaction model that includes partnerships with healthcare organizations and pharmaceutical companies. This business model often involves collaborative agreements where the company provides its innovative therapeutic solutions in exchange for licensing fees or shared revenue from product sales. The pricing structure is designed to accommodate various client needs, with a focus on long-term partnerships that emphasize scalability and integration of their high molecular therapies into existing healthcare frameworks. While specific pricing plans for flagship products are not disclosed, the revenue streams are bolstered by ongoing collaborations and the potential for direct sales to healthcare providers. The company plans to introduce new products designed to address chronic diseases, targeting specific international markets in Asia and Europe for expansion by 2027.
Who invested in Luofang Biotechnology
1 investor across 1 round
See all investors in Luofang Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 16, 2026
Amount
Undisclosed
Investors
Questions about Luofang Biotechnology
Who invested in Luofang Biotechnology?
Luofang Biotechnology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Luofang Biotechnology raised?
Luofang Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Luofang Biotechnology last raise money?
Luofang Biotechnology's most recent round on record is a Seed, in Apr 2026.
What does Luofang Biotechnology do?
Luofang Biotechnology, founded in 2025 and headquartered in Shenzhen, China, focuses on developing high molecular therapies for chronic health conditions.
Where is Luofang Biotechnology headquartered?
Luofang Biotechnology is headquartered in Shenzhen, China.
Which VCs invest in companies like Luofang Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back companies at Luofang Biotechnology's stage. Their profiles are linked below.
VCs to look at next
Raising like Luofang Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.